Synthesis 2009(2): 205-210  
DOI: 10.1055/s-0028-1083289
PAPER
© Georg Thieme Verlag Stuttgart ˙ New York

Synthesis of 1,4-Benzodiazepine-2,5-diones Using an Ionic Liquid as a Soluble Support

Hongwei Xie, Cuifen Lu, Guichun Yang*, Zuxing Chen
Ministry-of-Education Key Laboratory for the Synthesis and Application of Organic Functional Molecules, School of Chemistry and Chemical Engineering, Hubei University, Wuhan, Hubei, 430062, P. R. of China
e-Mail: yangguichun@hubu.edu.cn;
Further Information

Publication History

Received 31 July 2008
Publication Date:
19 December 2008 (online)

Abstract

The first report of the use of an ionic liquid as a soluble support for the synthesis of 1,4-benzodiazepine-2,5-diones is reported in this paper. This synthetic method is simple and efficient and the products are obtained in good yields. All of the products were characterized by IR, ¹H NMR, and ¹³C NMR.

    References

  • For recent articles on the syntheses and bioactivities of 1,4-benzodiazepine-2,5-diones, see:
  • 1a Kamal A. Reddy KL. Devaiah V. Synlett  2004,  2533 
  • 1b Kamal A. Ramana AV. Reddy KS. Tetrahedron Lett.  2004,  45:  818 
  • 1c Sabb AL. Vogel RL. Welmaker GS. Sabalski JE. Coupet J. Dunlop J. Rosenzweig-Lipson S. Harrison B. Bioorg. Med. Chem. Lett.  2004,  14:  2603 
  • 1d Li XY. Cao H. Zhang CC. Fuchs K. J. Med. Chem.  2003,  46:  5567 
  • 1e Parks DJ. LaFrance LV. Calvo RR. Milkiewicz KL. Gupta V. Lattanze J. Ramachandren K. Carver TE. Petrella EC. Cummings MD. Maguire D. Grasberger BL. Lu T. B. Bioorg. Med. Chem. Lett.  2005,  15:  765 
  • For solid-phase synthesis of 1,4-benzodiazepine-2,5-diones, see:
  • 2a Boojamra CG. Burow KM. Thompson LA. Ellman JA. J. Org. Chem.  1997,  62:  1240 
  • 2b Mayer JP. Zhang J. Bjergarde K. Lenz DM. Gaudino JJ. Tetrahedron Lett.  1996,  37:  8081 
  • 2c Hulme C. Peng J. Morton G. Salvino JM. Herpin T. Labaudiniere R. Tetrahedron Lett.  1998,  39:  7227 
  • 2d Kennedy AL. Fryer AM. Josey JA. Org. Lett.  2002,  4:  1167 
  • For recent reviews, see:
  • 3a Hermkens PHH. Ottenheijm HCJ. Rees D. Tetrahedron  1996,  52:  4527 
  • 3b Booth S. Hermkens PHH. Ottenheijm HCJ. Rees DC. Tetrahedron  1998,  54:  15385 
  • 3c Lorsbach BA. Kurth MJ. Chem. Rev.  1999,  99:  1549 
  • 3d Guillier F. Orain D. Bradley M. Chem. Rev.  2000,  100:  2091 
  • 3e Sammelson R. Kurth MJ. Chem. Rev.  2001,  101:  137 
  • 3f Krchòák V. Holladay W. Chem. Rev.  2002,  102:  61 
  • 3g Blaney P. Grigg R. Sridharan V. Chem. Rev.  2002,  102:  2607 
  • 4a Gravert DJ. Janda KD. Chem. Rev.  1997,  97:  489 
  • 4b Wentworth PJ. Janda KD. Chem. Commun.  1999,  1917 
  • 5a Toy PH. Janda KM. Acc. Chem. Res.  2000,  33:  546 
  • 5b Fishman A. Farrah ME. Zhong JH. Paramanantham S. Carrera C. Lee-Ruff E. J. Org.Chem.  2003,  68:  9843 
  • 5c Sauvagnat B. Kulig K. Lamaty F. Lazaro R. Martinez J. J. Comb. Chem.  2000,  2:  134 
  • 5d Chen S. Janda KD. J. Am. Chem. Soc.  1997,  119:  8724 
  • 5e Lin XF. Zhang J. Wang YG. Tetrahedron Lett.  2003,  44:  4113 
  • 5f Wang YG. Lin XF. Cui SL. Synlett  2004,  1175 
  • 6 For a recent review, see: Davis JHJ. Chem. Lett.  2004,  33:  1072 
  • 7a Fraga-Dubreuil J. Bazureau JP. Tetrahedron Lett.  2001,  42:  6097 
  • 7b Miao W. Chan TH. Org. Lett.  2003,  5:  5003 
  • 7c Fraga-Dubreuil J. Famelart MH. Bazureau JP. Org. Process Res. Dev.  2002,  6:  374 
  • 7d Fraga-Dubreuil J. Bazureau JP. Tetrahedron  2003,  59:  6121 
  • 8a Peng HD. Huang YL. Yang JH. Chen ZX. Yang GC. Comb. Chem. High Throughput Screening  2007,  10:  257 
  • 8b Zhang HQ. Yang GC. Chen JN. Chen ZX. Synthesis  2004,  3055 
  • 8c Rao Z. Peng HD. Yang GC. Chen ZX. Comb. Chem. High Throughput Screening  2006,  9:  1743 
  • 8d Chen ZX. Yue GZ. Lu CF. Yang GC. Synlett  2004,  1231 
  • 8e Yue GZ. Wan YD. Song SJ. Yang GC. Chen ZX. Bioorg. Med. Chem. Lett.  2005,  15:  453